Deuterium Metabolic Imaging in People with Multiple Sclerosis

Abroad (travel likely)Recruiting

Conditions

Multiple Sclerosis (MS) - Relapsing-remitting

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Aarhus University, Aarhus C, Denmark
Contact: Study coordinator (Tobias Gæmelke) · gaemelke@ph.au.dk · 28264508

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Multiple Sclerosis (MS) · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Primary Progressive

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Francisco, United States

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE4

Kaohsiung City, Taiwan · Taichung, Taiwan

Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity

Multiple Sclerosis (MS) - Relapsing-remitting

Abroad (travel likely)Recruiting

Nice, France · Nîmes, France

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Multiple Sclerosis · RRMS · Relapsing Remitting MS

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States